We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Inkjet Printer May Produce Simple Tool to Detect Diseases and Contaminants

By LabMedica International staff writers
Posted on 19 Apr 2015
Researchers have developed new technology for printing paper biosensors that could rapidly detect molecules for many applications, including point-of-care diagnosis of bacterial and viral infections and detection of food and environmental contaminants.

Researchers at McMaster University (Hamilton, ON, Canada) developed the new platform, the latest in a progression of paper-based screening technologies to enable clear results in the form of letters and symbols that appear on the test paper to indicate presence of infection or contamination in people, food, or environment. More...
Patients could receive diagnoses of infections in their doctors’ offices, saving trips to the lab and critical time. Consumers may benefit from packaging that could give simple text warnings if food is contaminated with pathogenic E. coli or Salmonella.

“The simplicity of use makes the system easy and cheap to implement in the field or doctor’s office,” said Prof. John Brennan, director of McMaster’s Biointerfaces Institute, “Imagine being able to clearly identify contaminated meat, vegetables, or fruit. For patients suspected of having infectious diseases like C. difficile, this technology allows doctors to quickly and simply diagnose their illnesses, saving time and expediting what could be life-saving treatments. This method can be extended to virtually any compound, be it a small molecule, bacterial cell, or virus.”

The research, in its formative stage, addresses key problems facing current paper-based biosensing techniques which are labor-intensive, sometimes costly and inconvenient, and often difficult to mass produce. With state-of-the-art methods to produce “bio-inks”, conventional office ink-jet printers can be used to print man-made DNA molecules with very high molecular weight on paper. The sheer size of the DNA, which produces a signal when a specific disease biomarker is present, is enough to ensure it remains immobilized and therefore stable. The paper sensor emerges from the printer ready- and easy-to-use, like pH paper.

The new technology could be used in many fields where quick answers to important questions are critical. “We could conceivably adapt this for numerous applications, including rapid detection of cancer or monitoring toxins in the water supply,” said Prof. Brennan, “There are hundreds of possibilities.”

The study, by Carrasquilla C. et al., was published online March 27, 2015, in the journal Chemistry.

Related Links:

McMaster University



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
New
Alzheimer's Disease Biomarker Assay
Elecsys Phospho-Tau (217P) Plasma
New
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: 123RF

UK Project Advances Blood-Based Dementia Testing Toward Routine Clinical Care

Dementia is the leading cause of death in the UK, accounting for almost one in eight deaths, with more than 72,000 people dying from dementia, including Alzheimer’s disease, in 2025. Despite this burden,... Read more

Microbiology

view channel
Image: Overview of a rapid diagnostic workflow for fungal bloodstream infections (Photo courtesy of Professor Hiroki Takahashi and IMO, Chiba University, Japan)

Genomic Workflow Identifies Fungal Pathogens Before Blood Cultures Turn Positive

Fungal bloodstream infections pose a major threat to hospitalized patients. Candida species cause most invasive fungal infections worldwide and are among the leading causes of hospital-acquired bloodstream... Read more

Industry

view channel
Image: TruVerus is designed to deliver a broad menu of routine blood tests from a small blood sample on a single, automated benchtop platform (Photo courtesy of Truvian Health)

Collaboration Advances Automated Benchtop Platform for Routine Blood Testing

Routine blood testing is central to clinical decision-making, but access can vary across laboratory and healthcare settings. Broader use of automated benchtop platforms may help integrate testing more... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.